T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$2.57B |
| 2 |
GE Aerospace
GE
|
+$1.8B |
| 3 |
UnitedHealth
UNH
|
+$1.63B |
| 4 |
Marriott International
MAR
|
+$1.62B |
| 5 |
Apple
AAPL
|
+$1.3B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$2.87B |
| 2 |
JPMorgan Chase
JPM
|
+$1.64B |
| 3 |
Nike
NKE
|
+$1.59B |
| 4 |
Becton Dickinson
BDX
|
+$1.46B |
| 5 |
Alibaba
BABA
|
+$1.32B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.97% |
| 2 | Healthcare | 18.52% |
| 3 | Consumer Discretionary | 13.26% |
| 4 | Financials | 12.08% |
| 5 | Communication Services | 10.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1501
US Foods
USFD
$24B
| $1.95M | ﹤0.01% |
110,283
+23,829
| +28% | +$798K |
|
1502
Zscaler
ZS
$30.4B
| $1.95M | ﹤0.01% |
31,986
-4,186
| -12% | -$230K |
|
1503
First Citizens BancShares
FCNCA
$25.6B
| $1.94M | ﹤0.01% |
5,817
+1,347
| +30% | +$624K |
|
|
LHCG
1504
DELISTED
LHC Group LLC
LHCG
| $1.93M | ﹤0.01% |
13,779
+4,456
| +48% | +$621K |
|
1505
Wyndham Hotels & Resorts
WH
$5.49B
| $1.93M | ﹤0.01% |
61,146
+3,563
| +6% | +$181K |
|
1506
Intercorp Financial Services
IFS
$6.06B
| $1.93M | ﹤0.01% |
+69,480
| New | +$2.63M |
|
|
LM
1507
DELISTED
Legg Mason, Inc.
LM
| $1.93M | ﹤0.01% |
39,410
+6,981
| +22% | +$305K |
|
1508
Seaboard Corp
SEB
$4.02B
| $1.92M | ﹤0.01% |
683
-236
| -26% | -$854K |
|
1509
LPL Financial
LPLA
$29.7B
| $1.91M | ﹤0.01% |
35,118
+4,383
| +14% | +$353K |
|
1510
TD Synnex
SNX
$20.4B
| $1.91M | ﹤0.01% |
52,218
+15,358
| +42% | +$942K |
|
|
VRNT
1511
DELISTED
Verint Systems
VRNT
| $1.9M | ﹤0.01% |
86,521
+19,602
| +29% | +$527K |
|
|
EVBG
1512
DELISTED
Everbridge, Inc. Common Stock
EVBG
| $1.89M | ﹤0.01% |
17,786
+472
| +3% | +$46.3K |
|
1513
Deckers Outdoor
DECK
$12.7B
| $1.89M | ﹤0.01% |
84,684
+15,432
| +22% | +$429K |
|
1514
WaFd
WAFD
$2.79B
| $1.89M | ﹤0.01% |
72,696
+294
| +0.4% | +$9.39K |
|
|
WMGI
1515
DELISTED
Wright Medical Group Inc
WMGI
| $1.87M | ﹤0.01% |
65,316
-6,256
| -9% | -$186K |
|
1516
CNO Financial Group
CNO
$5.02B
| $1.86M | ﹤0.01% |
150,437
-2,223
| -1% | -$36.4K |
|
1517
Brown-Forman Class A
BF.A
$13B
| $1.85M | ﹤0.01% |
36,000
| – | – |
|
1518
Autoliv
ALV
$8.85B
| $1.84M | ﹤0.01% |
40,109
-6,533
| -14% | -$449K |
|
1519
Wingstop
WING
$3.05B
| $1.84M | ﹤0.01% |
23,149
-200,100
| -90% | -$17.1M |
|
|
TRTN
1520
DELISTED
Triton International Limited
TRTN
| $1.84M | ﹤0.01% |
71,089
-3,880
| -5% | -$133K |
|
1521
BILL Holdings
BILL
$4.85B
| $1.83M | ﹤0.01% |
53,585
-347,392
| -87% | -$16.4M |
|
1522
Allison Transmission
ALSN
$10.2B
| $1.83M | ﹤0.01% |
56,035
-2,139
| -4% | -$89.2K |
|
1523
Cullen/Frost Bankers
CFR
$10.4B
| $1.81M | ﹤0.01% |
32,366
+1,423
| +5% | +$116K |
|
|
SRC
1524
DELISTED
SPIRIT REALTY CAPITAL, INC.
SRC
| $1.8M | ﹤0.01% |
68,996
+10,290
| +18% | +$466K |
|
1525
Cyclerion Therapeutics
CYCN
$18.4M
| $1.8M | ﹤0.01% |
+33,934
| New | +$2.42M |
|
Similar funds
T. Rowe Price Associates's Q1 2020 Portfolio in Review
As of Q1 2020, T. Rowe Price Associates held 2,612 positions worth $632B, down 18% from $771B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
T. Rowe Price Associates's Q1 2020 filing shows 87 new, 1,525 increased, 823 reduced and 103 closed positions. Its largest new stake was Philips: 33,363,001 shares worth $1.07B. The largest sale was Boeing, an estimated $2.87B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q1 2020 buy was Philips: 33,363,001 shares worth $1.07B.
- T. Rowe Price Associates added most to Humana in Q1 2020, an estimated $2.57B increase.
- T. Rowe Price Associates's biggest Q1 2020 reduction was Boeing, cutting an estimated $2.87B.
- T. Rowe Price Associates fully exited Wellcare Health Plans, Inc. in Q1 2020, selling an estimated $846M.
- T. Rowe Price Associates's ten largest holdings make up 24% of its $632B portfolio in Q1 2020.
- T. Rowe Price Associates opened 87 new positions and closed 103 in Q1 2020.
- T. Rowe Price Associates's portfolio value fell 18% quarter-over-quarter to $632B.
Based on T. Rowe Price Associates's 13F filing for Q1 2020, filed 15 May 2020.